Blog

Find out more about what is happening at Cmed

Cmed to Demonstrate encapsia at Two Leading Oncology Meetings
13 Nov

Cmed to Demonstrate encapsia at Two Leading Oncology Meetings

13 Nov 2017

Cloud-based Clinical Data Suite to be Showcased at Clinical Operations in Oncology Trials Europe and the ASH Annual Meeting Cmed, an oncology focused, innovative technology-led CRO, today announced that it will showcase its encapsia® clinical data suite at two leading oncology meetings, Clinical Operations in Oncology Trials Europe, taking place 5-6 December in Munich, Germany, and the ASH Annual Meeting, taking place 9-12 December in Atlanta, GA. As a full-service CRO, Cmed has a strong reputation in delivering complex and demanding clinical trials across numerous oncology types, including various haematological indications, immuno-oncology, breast, lung, prostate and colorectal....

Read post
Cmed showcasing encapsia at PCT Europe
01 Nov

Cmed showcasing encapsia at PCT Europe

01 Nov 2017

Cmed to Showcase Advanced Data Insights and Analytics Capabilities of encapsia® Clinical Data Suite at Partnerships in Clinical Trials Europe Cmed, an innovative technology-led CRO, will demonstrate its encapsia® clinical data suite at Partnerships in Clinical Trials Europe, taking place 28-29 November 2017 in Amsterdam, The Netherlands. Currently used in trials with nine Pharma companies, including two of the top five, for a variety of electronic data capture (EDC) and direct data capture eSource clinical trials, the solution provides sponsors and their partners with a single point of access for live views of data at any point in a clinical trial....

Read post
Rare diseases - still rare disease, but no longer orphans
13 Oct

Rare diseases - still rare disease, but no longer orphans

13 Oct 2017

Historically, rare diseases were also called orphan diseases. They were orphans because no one was developing therapies for them. There was no chance that a company would be able to recover its investment if it spent time and money developing a treatment for such a small population. Some of these diseases are no longer ‘orphans’ in this regard, because the bio-pharmaceutical industry is now ‘adopting’ them slowly, but steadily. Nonetheless, rarity remains the defining feature of these diseases....

Read post
Love a duck! Cmed win charity race!!
19 Sep

Love a duck! Cmed win charity race!!

19 Sep 2017

The annual Bega duck race in Timisoara, Romania, went off with a splash on Sunday 3rd September, as hundreds of rubber ducks took to the water and went beak-to-beak in some of the most intense racing ever seen across the river Bega. Representing Cmed in the hotly contested “Sponsor Race” was Doctor Duck. Crowds cheered on as ten rubber ducks in a row bobbed down the river in the big race of the day, eagerly awaiting the winner with bated breath....

Read post
Dpharm Disruptive Innovations 2017 in Review
15 Sep

Dpharm Disruptive Innovations 2017 in Review

15 Sep 2017

Can you say, “Welcome to the wide, wonderful world of wearables”, three times fast? Disruptive Innovations landed in Boston last week, once again bringing together Innovation Teams and Market Disruptors to listen, learn and share how they are looking to leap forward in clinical trials. Wearables continued to be a topic of discussion throughout the two day conference. Whereas in the past, wearables were introduced as a possibility, this year established sponsors were showing off successful proof of concepts and new tech vendors were bringing in gadgets that went well beyond using a Fitbit to track steps....

Read post

Want to learn more?

Please feel free to contact us if you would like to learn more about our skills and experience. We are friendly, open and here to help.

Contact us